中国医疗器械杂志
中國醫療器械雜誌
중국의료기계잡지
CHINESE JOURNAL OF MEDICAL INSTRUMENTATION
2015年
1期
68-71
,共4页
解传滨%徐寿平%徐伟%丛小虎%葛瑞刚%巩汉顺%鞠忠建%戴相昆
解傳濱%徐壽平%徐偉%叢小虎%葛瑞剛%鞏漢順%鞠忠建%戴相昆
해전빈%서수평%서위%총소호%갈서강%공한순%국충건%대상곤
剂量验证%全骨髓照射(TMI)%容积旋转调强放射治疗(VMAT)%螺旋断层放射治疗(HT)
劑量驗證%全骨髓照射(TMI)%容積鏇轉調彊放射治療(VMAT)%螺鏇斷層放射治療(HT)
제량험증%전골수조사(TMI)%용적선전조강방사치료(VMAT)%라선단층방사치료(HT)
dose verification%total morrow irradiation (TMI)%volumetric modulated arc therapy (VMAT)%helical tomotherapy (HT)
探讨利用ArcCHECK对VMAT(Volumetric Modulated Arc Therapy)和HT (Helical Tomotherapy)全骨髓照射(TMI)超长靶区计划的验证方法。选取8例全身扫描患者,分别设计TMI计划。采用ArcCHECK对两组计划头颈、胸腹及盆腔三部位行验证分析。VMAT组采用模体Merge功能通过平移治疗床实现, HT组采用双计划(参考/执行)法得以完成,三部位验证通过率分别为98.9%±1.9%/94.3%±1.5%、98.4%±1.8%/96.5%±1.2%、97.4%±2.1%/94.1%±1.9%。表明利用ArcCHECK的Merge功能能较好地完成VMAT超长靶区的验证,采用双计划法实现了对HT超长靶区及远离中心部分靶区的验证。
探討利用ArcCHECK對VMAT(Volumetric Modulated Arc Therapy)和HT (Helical Tomotherapy)全骨髓照射(TMI)超長靶區計劃的驗證方法。選取8例全身掃描患者,分彆設計TMI計劃。採用ArcCHECK對兩組計劃頭頸、胸腹及盆腔三部位行驗證分析。VMAT組採用模體Merge功能通過平移治療床實現, HT組採用雙計劃(參攷/執行)法得以完成,三部位驗證通過率分彆為98.9%±1.9%/94.3%±1.5%、98.4%±1.8%/96.5%±1.2%、97.4%±2.1%/94.1%±1.9%。錶明利用ArcCHECK的Merge功能能較好地完成VMAT超長靶區的驗證,採用雙計劃法實現瞭對HT超長靶區及遠離中心部分靶區的驗證。
탐토이용ArcCHECK대VMAT(Volumetric Modulated Arc Therapy)화HT (Helical Tomotherapy)전골수조사(TMI)초장파구계화적험증방법。선취8례전신소묘환자,분별설계TMI계화。채용ArcCHECK대량조계화두경、흉복급분강삼부위행험증분석。VMAT조채용모체Merge공능통과평이치료상실현, HT조채용쌍계화(삼고/집행)법득이완성,삼부위험증통과솔분별위98.9%±1.9%/94.3%±1.5%、98.4%±1.8%/96.5%±1.2%、97.4%±2.1%/94.1%±1.9%。표명이용ArcCHECK적Merge공능능교호지완성VMAT초장파구적험증,채용쌍계화법실현료대HT초장파구급원리중심부분파구적험증。
To investigate the patient-specific dose verification method using ArcCHECK for total marrow irradiation (TMI) with Volumetric Modulated Arc Therapy(VMAT) and Helical Tomotherapy(HT) . The kVCT images col ected from 8 patients were respectively designed for RapidArc and Tomotherapy plans in total marrow irradiation. ArcCHECK was used for dose verification for the head-neck, chest-abdomen and pelvic. The merging function of ArcCHECK was used in VMAT and the method of double plans(reference and delivery plans) were used in HT. The γ-analysis passing rates for the head-neck, chest-abdomen, pelvic were 98.9%±1.9%, 98.4%±1.8%, 97.4%±2.1% for VMAT plans and 94.3%±1.5%, 96.5±1.2%, 94.1%±1.9% for HT plans. The results show that using the merging function of ArcCHECK can achieve the dose verification wel for VMAT plans with TMI, The method of double plans was done for the dose verification of HT plans with TMI as wel as the plans with the targets keeping away from the set-up center.